Literature DB >> 9145726

Wound infections following spinal fusion with posterior segmental spinal instrumentation.

J W Perry1, J Z Montgomerie, S Swank, D S Gilmore, K Maeder.   

Abstract

Twenty-three of 238 patients (9.7%) developed wound infections following segmental spinal instrumentation. When the infected group and a matched control group were compared, the infected group had a significantly higher number of patients with cerebral palsy and myelodysplasia (nonambulatory), patients with wound hematomas, patients with fusions that extended into the sacral region, and patients who were incontinent of urine. A high incidence of infections with gram-negative aerobic bacilli correlated with the extension of the surgery into the sacral region and bowel and/or bladder incontinence. Prophylactic antibiotics with broader coverage for gram-negative bacilli may be warranted for these procedures. Postoperative wound infections were managed by surgical drainage and debridement as well as antibiotics. Removal of the hardware was not necessary to control the infection in these patients who underwent segmental spinal instrumentation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9145726     DOI: 10.1093/clind/24.4.558

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  24 in total

Review 1.  Risk factors for surgical site infection following pediatric spinal deformity surgery: a systematic review and meta-analysis.

Authors:  Fei Meng; Junming Cao; Xianzhong Meng
Journal:  Childs Nerv Syst       Date:  2015-02-24       Impact factor: 1.475

2.  The use of antibiotic-impregnated fibrin sealant for the prevention of surgical site infection associated with spinal instrumentation.

Authors:  Katsuhiro Tofuku; Hiroaki Koga; Mitsuhiro Yanase; Setsuro Komiya
Journal:  Eur Spine J       Date:  2012-07-22       Impact factor: 3.134

Review 3.  Infections in spinal instrumentation.

Authors:  Antoine Gerometta; Juan Carlos Rodriguez Olaverri; Fabian Bitan
Journal:  Int Orthop       Date:  2012-01-05       Impact factor: 3.075

4.  Wound conditioning by vacuum assisted closure (V.A.C.) in postoperative infections after dorsal spine surgery.

Authors:  Ludwig Labler; Marius Keel; Otmar Trentz; Michael Heinzelmann
Journal:  Eur Spine J       Date:  2006-07-12       Impact factor: 3.134

5.  Preoperative embolization and local hemostatic agents in palliative decompression surgery for spinal metastases of renal cell carcinoma.

Authors:  Nikita Zaborovskii; Dmitrii Ptashnikov; Dmitrii Mikaylov; Sergei Masevnin; Oleg Smekalenkov
Journal:  Eur J Orthop Surg Traumatol       Date:  2018-03-10

6.  Association between Asymptomatic Urinary Tract Infection and Postoperative Spine Infection in Elderly Women : A Retrospective Analysis Study.

Authors:  Seung-Eun Lee; Kyoung-Tae Kim; Yong-Sook Park; Young-Baeg Kim
Journal:  J Korean Neurosurg Soc       Date:  2010-04-30

7.  Aerobic and anaerobic microbiology of surgical-site infection following spinal fusion.

Authors:  I Brook; E H Frazier
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

8.  Single-use instrumentation in posterior lumbar fusion could decrease incidence of surgical site infection: a prospective bi-centric study.

Authors:  Stéphane Litrico; Geoffrey Recanati; Antoine Gennari; Cédric Maillot; Mo Saffarini; Jean-Charles Le Huec
Journal:  Eur J Orthop Surg Traumatol       Date:  2015-09-01

Review 9.  V.A.C. Therapy in the management of paediatric wounds: clinical review and experience.

Authors:  Mona Baharestani; Ibrahim Amjad; Kim Bookout; Tatjana Fleck; Allen Gabriel; David Kaufman; Shannon Stone McCord; Donald C Moores; Oluyinka O Olutoye; Jorge D Salazar; David H Song; Steven Teich; Subhas Gupta
Journal:  Int Wound J       Date:  2009-08       Impact factor: 3.315

10.  The diagnosis and management of infection following instrumented spinal fusion.

Authors:  Iona Collins; James Wilson-MacDonald; George Chami; Will Burgoyne; P Vinayakam; Tony Berendt; Jeremy Fairbank
Journal:  Eur Spine J       Date:  2007-12-13       Impact factor: 3.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.